FISPB
ABBV icon

Fideuram - Intesa Sanpaolo Private Banking’s AbbVie ABBV Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1M Sell
155,208
-30,553
-16% -$6.57M 1.17% 16
2026
Q1 		$40.4M Buy
185,761
+26,142
+16% +$5.8M 1.42% 12
2025
Q4 		$36.5M Buy
+159,619
New +$36.4M 1.31% 11

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's ABBV Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its AbbVie (ABBV) stake by 16% in Q2 2026, selling an estimated $6.57M and leaving 155,208 shares worth $39.1M. The position accounts for 1.17% of the portfolio, ranked #16.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.4M in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 155,208 shares of AbbVie worth $39.1M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 30,553 AbbVie shares in Q2 2026, an estimated $6.57M.
  • AbbVie made up 1.17% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #16 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's AbbVie position peaked at $40.4M in Q1 2026.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.